[F16. In regulation 4—
(a)in paragraph (4)(d)—
(i)in paragraph (i) insert “UK” before “marketing authorisation”;
(ii)after paragraph (i) insert—
“(ia)the EU marketing authorisation,”;
(b)in paragraph (6) for “269 (offences relating to packaging and package leaflets: other persons)” substitute “269 (offences relating to packaging and package leaflets in Great Britain: other persons), 269A (offences relating to packaging and package leaflets in Northern Ireland: other persons)”.]
Textual Amendments
F1Reg. 6 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 3
Commencement Information
I1Reg. 6 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1